EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 26 / No 8-9 (Août-Septembre 2010) Med Sci (Paris), 26 8-9 (2010) 681-685 References
Free Access
Issue
Med Sci (Paris)
Volume 26, Number 8-9, Août-Septembre 2010
Page(s) 681 - 685
Section Nouvelles
DOI https://doi.org/10.1051/medsci/2010268-9681
Published online 15 August 2010
  1. Fuchs E. Scratching the surface of skin development. Nature 2007 ; 445 : 834-42. [Google Scholar]
  2. Candi E, Schmidt R, Melino G. The cornified envelope: a model of cell death in the skin. Nat Rev Mol Cell Biol 2005 ; 6 : 328-40. [Google Scholar]
  3. Caubet C, Jonca N, Brattsand M, et al. Degradation of corneodesmosome proteins by two serine proteases of the kallikrein family, SCTE/KLK5/hK5 and SCCE/KLK7/ hK7. J Invest Dermatol 2004 ; 122 : 1235-44. [Google Scholar]
  4. Kishibe M, Bando Y, Terayama R, et al. Kallikrein 8 is involved in skin desquamation in cooperation with other kallikreins. J Biol Chem 2007 ; 282 : 5834-41. [Google Scholar]
  5. Stefansson K, Brattsand M, Ny A, et al. Kallikrein-related peptidase 14 may be a major contributor to trypsin-like proteolytic activity in human stratum corneum. Biol Chem 2006 ; 387 : 761-8. [Google Scholar]
  6. Borgono CA, Michael IP, Komatsu N, et al. A potential role for multiple tissue kallikrein serine proteases in epidermal desquamation. J Biol Chem 2007 ; 282 : 3640-52. [Google Scholar]
  7. Bernard D, Mehul B, Thomas-Collignon A, et al. Analysis of proteins with caseinolytic activity in a human stratum corneum extract revealed a yet unidentified cysteine protease and identified the so-called stratum corneum thiol protease as cathepsin l2. J Invest Dermatol 2003 ; 120 : 592-600. [Google Scholar]
  8. Igarashi S, Takizawa T, Yasuda Y, et al. Cathepsin D, but not cathepsin E, degrades desmosomes during epidermal desquamation. Br J Dermatol 2004 ; 151 : 355-61. [Google Scholar]
  9. Deraison C, Bonnart C, Lopez F, et al. LEKTI Fragments specifically inhibit KLK5, KLK7, and KLK14 and control desquamation through a pH-dependent interaction. Mol Biol Cell 2007 ; 18 : 3607-19. [Google Scholar]
  10. Sallenave JM. The role of secretory leukocyte proteinase inhibitor and elafin (elastase-specific inhibitor/skin-derived antileukoprotease) as alarm antiproteinases in inflammatory lung disease. Respir Res 2000 ; 1 : 87-92. [Google Scholar]
  11. Schalkwijk J, de Roo C, de Jongh GJ. Skin-derived antileukoproteinase (SKALP), an elastase inhibitor from human keratinocytes. Purification and biochemical properties. Biochim Biophys Acta 1991 ; 1096 : 148-54. [Google Scholar]
  12. Zeeuwen PL, van Vlijmen-Willems IM, Olthuis D, et al. Evidence that unrestricted legumain activity is involved in disturbed epidermal cornification in cystatin M/E deficient mice. Hum Mol Genet 2004 ; 13 : 1069-79. [Google Scholar]
  13. Komatsu N, Takata M, Otsuki N, et al. Elevated stratum corneum hydrolytic activity in Netherton syndrome suggests an inhibitory regulation of desquamation by SPINK5-derived peptides. J Invest Dermatol 2002 ; 118 : 436-43. [Google Scholar]
  14. Comel M. Ichtyosis linearis circumflexa. Dermatologica 1949 ; 98 : 133-6. [Google Scholar]
  15. Netherton EW. A unique case of Trichorrexis Invaginata. Arch Dermatol 1958 ; 78 : 483-7. [Google Scholar]
  16. Judge MR, Morgan G, Harper JL. A clinical and immunological study of Netherton’s syndrome. Br J Dermatol 1994 ; 131 : 615-21. [Google Scholar]
  17. Chavanas S, C Bodemer, A Rochat, et al., Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome. Nat Genet 2000 ; 25 : 141-2. [Google Scholar]
  18. Bitoun E, Chavanas S, Irvine AD, et al. Netherton syndrome: disease expression and spectrum of SPINK5 mutations in 21 families. J Invest Dermatol 2002 ; 118 : 352-61. [Google Scholar]
  19. Bitoun E, Micheloni A, Lamant L, et al., LEKTI proteolytic processing in human primary keratinocytes, tissue distribution and defective expression in Netherton syndrome. Hum Mol Genet 2003 ; 12 : 2417-30. [Google Scholar]
  20. Descargues P, Deraison C, Bonnart C, et al. Spink5-deficient mice mimic Netherton syndrome through degradation of desmoglein 1 by epidermal protease hyperactivity. Nat Genet 2005 ; 37 : 56-65. [Google Scholar]
  21. Bonnart C, Deraison C, Lacroix M, et al. Elastase 2 is expressed in human and mouse epidermis and impairs skin barrier function in Netherton syndrome through filaggrin and lipid misprocessing. J Clin Invest 2010 ; 120 : 871-82. [Google Scholar]
  22. Swartzendruber DC, Wertz PW, Kitko DJ, et al. Molecular models of the intercellular lipid lamellae in mammalian stratum corneum. J Invest Dermatol 1989 ; 92 : 251-7. [Google Scholar]
  23. Sandilands A, Sutherland C, Irvine AD, et al. Filaggrin in the frontline: role in skin barrier function and disease. J Cell Sci 2009 ; 122 : 1285-94. [Google Scholar]
  24. Descargues P, Deraison C, Bonnart C, Hovnanian A. Syndrome de Netherton : un modèle d’étude de la régulation de la desquamation. Med Sci (Paris) 2005 ; 21 : 457-8. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.